Avita Therapeutics Inc. buy BiotechBee
Start price
24.06.23
/
70%
€14.00
Target price
31.01.27
€30.00
Performance (%)
-27.86%
End price
02.12.23
€10.10
Summary
This prediction ended on 02.12.23 with a price of €10.10. The prediction for Avita Therapeutics Inc. disappointed with a performance of -27.86%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Avita Therapeutics Inc. | -2.027% | -2.027% |
| iShares Core DAX® | 0.192% | 3.121% |
| iShares Nasdaq 100 | 1.245% | 5.051% |
| iShares Nikkei 225® | -0.992% | 1.101% |
| iShares S&P 500 | 0.154% | 2.864% |
According to BiotechBee what are the pros and cons of Avita Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Avita Therapeutics Inc. diskutieren
Buy mit Kursziel 30,0
In the thread Trading Avita Therapeutics Inc.
Stopped prediction by BiotechBee for Avita Therapeutics Inc.
Avita Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.10
24.12.22
24.12.22
€9.00
31.12.25
31.12.25
139.34%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
